Javier San Martin

(DR. Javier San Martin M.D.)

Currently holds a position at Arrowhead Pharmaceuticals Inc

Positions
Position Company Period
Chief Medical Officer Arrowhead Pharmaceuticals Inc Nov. 18, 2019 -
Vice President - Clinical Development Ultragenyx Pharmaceutical Inc Dec. 1, 2013 - Jan. 1, 2014
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-01-08 2024-01-05
PS Planned sale
4,403 -2.2%
35.64
156,923 USD 		4,403 -2.2% 35.64 156,923 USD
2024-01-08 2024-01-05
PS Planned sale
3,100 -1.5%
35.03
108,593 USD 		3,100 -1.5% 35.03 108,593 USD
2024-01-08 2024-01-05
PS Planned sale
800 -0.4%
34.11
27,288 USD 		800 -0.4% 34.11 27,288 USD
2022-11-22 2022-11-21
PS Planned sale
200 -0.2%
30.62
6,124 USD 		200 -0.2% 30.62 6,124 USD
2022-11-22 2022-11-21
PS Planned sale
19,300 -17.4%
29.98
578,614 USD 		19,300 -17.4% 29.98 578,614 USD
2021-11-22 2021-11-19
PS Planned sale
100 -0.1%
70.99
7,099 USD 		100 -0.1% 70.99 7,099 USD
2021-11-22 2021-11-19
PS Planned sale
5,696 -4.9%
70.01
398,777 USD 		5,696 -4.9% 70.01 398,777 USD
2021-11-22 2021-11-19
PS Planned sale
13,704 -10.5%
69.01
945,713 USD 		13,704 -10.5% 69.01 945,713 USD
2020-11-20 2020-11-19
PS Planned sale
19,500 -13.0%
69.39
1,353,105 USD 		19,500 -13.0% 69.39 1,353,105 USD